 |
Interferon alfa-nl |
|---|---|
| Trade Name | Wellferon |
| Orphan Indication | Human papillomavirus in patients with severe resistant/recurrent respiratory (laryngeal) papillomatosis |
| USA Market Approval | USA |
| USA Designation Date | 1987-10-16 00:00:00 |
| Sponsor | Glaxo Wellcome Inc.;5 Moore Drive;Research Triangle Park, North Carolina, 27709 |
